These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1133 related articles for article (PubMed ID: 37934614)

  • 21. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
    Alfonsetti M; Castelli V; d'Angelo M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
    Ciernikova S; Sevcikova A; Drgona L; Mego M
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota-Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics.
    Dahiya D; Nigam PS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synbiotics, prebiotics and probiotics for solid organ transplant recipients.
    Cooper TE; Scholes-Robertson N; Craig JC; Hawley CM; Howell M; Johnson DW; Teixeira-Pinto A; Jaure A; Wong G
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014804. PubMed ID: 36126902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the microbiome to improve human health with the approach of personalized medicine: Latest aspects and current updates.
    Shukla V; Singh S; Verma S; Verma S; Rizvi AA; Abbas M
    Clin Nutr ESPEN; 2024 Oct; 63():813-820. PubMed ID: 39178987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism.
    Lambert K; Rinninella E; Biruete A; Sumida K; Stanford J; Raoul P; Mele MC; Wang AY; Mafra D
    J Ren Nutr; 2023 Nov; 33(6S):S30-S39. PubMed ID: 37632511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota and its metabolites in Alzheimer's disease: from pathogenesis to treatment.
    Zou X; Zou G; Zou X; Wang K; Chen Z
    PeerJ; 2024; 12():e17061. PubMed ID: 38495755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis.
    Ullah H; Tovchiga O; Daglia M; Khan H
    Curr Neuropharmacol; 2021; 19(11):1966-1983. PubMed ID: 33596808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of the Importance of Biotics in Gut Barrier Integrity.
    Kocot AM; Jarocka-Cyrta E; Drabińska N
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review.
    Baldi S; Mundula T; Nannini G; Amedei A
    World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prebiotics, probiotics, synbiotics and postbiotics to adolescents in metabolic syndrome.
    Luzzi A; Briata IM; Di Napoli I; Giugliano S; Di Sabatino A; Rescigno M; Cena H
    Clin Nutr; 2024 Jun; 43(6):1433-1446. PubMed ID: 38704983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Methods for Gut Microbiota Modification in Lipopolysaccharide-Associated Encephalopathy.
    Li S; Guo H; Xu X; Hua R; Zhao Q; Li J; Lv J; Li J
    Shock; 2021 Nov; 56(5):824-831. PubMed ID: 33595259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMN synbiotics intervention modulates gut microbiota and metabolism in APP/PS1 Alzheimer's disease mouse models.
    Zhang J; Zhao X; Xu H; Liu X; He Y; Tan X; Gu J
    Biochem Biophys Res Commun; 2024 Sep; 726():150274. PubMed ID: 38924882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotics, prebiotics, synbiotics, and fecal microbiota transplantation in the treatment of behavioral symptoms of autism spectrum disorder: A systematic review.
    Tan Q; Orsso CE; Deehan EC; Kung JY; Tun HM; Wine E; Madsen KL; Zwaigenbaum L; Haqq AM
    Autism Res; 2021 Sep; 14(9):1820-1836. PubMed ID: 34173726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota.
    Flaig B; Garza R; Singh B; Hamamah S; Covasa M
    Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.
    Nohesara S; Abdolmaleky HM; Thiagalingam S; Zhou JR
    Epigenomics; 2024 Jan; 16(1):57-77. PubMed ID: 38088063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics, Prebiotics and Postbiotics on Mitigation of Depression Symptoms: Modulation of the Brain-Gut-Microbiome Axis.
    Chudzik A; Orzyłowska A; Rola R; Stanisz GJ
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer's Disease.
    Wang Y; Dykes GA
    CNS Neurol Disord Drug Targets; 2022; 21(1):14-25. PubMed ID: 34365962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.